Cerebral vasoconstriction and stroke after use of serotonergic drugs.
Petro
Denis J
DJ
D000928:Antidepressive Agents / Q000009:adverse effects; D001921:Brain / Q000098:blood supply*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D019587:Dietary Supplements / Q000009:adverse effects; D004335:Drug and Narcotic Control; D004809:Ephedrine / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D009203:Myocardial Infarction / Q000139:chemically induced; D023303:Oxazolidinones / Q000009:adverse effects; D012306:Risk; D018490:Serotonin Agents / Q000009:adverse effects*; D020521:Stroke / Q000139:chemically induced*; D018170:Sumatriptan / Q000009:adverse effects; D013577:Syndrome; D014363:Tryptamines; D014661:Vasoconstriction / Q000187:drug effects*
D000928:Antidepressive Agents; D023303:Oxazolidinones; D018490:Serotonin Agents; D014363:Tryptamines; C089750:zolmitriptan; D018170:Sumatriptan; D004809:Ephedrine